Metabolic syndrome components can predict C reactive protein concentration in adolescents;Componentes del sindrome metabólico pueden predecir concentración de proteína C reactiva en adolescentes

Nutricion Hospitalaria

Volumn 28, Issue 5, 2013, Pages 1580-1586

  da Cruz, Larissa Leandro ^a   Daniele Cardoso, Luciane ^b   Pala, Daniela ^a   de Paula, Heberth ^b   Alves Lamounier, Joel ^c   Mariano Silva, Camilo Adalton ^a   Pinheiro Volp, Ana Carolina ^a   de Freitas, Renata Nascimento ^a,b  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Adolescents; C reactive protein; Metabolic syndrome x; Obesity; Risk factors

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADOLESCENT; ARTICLE; BLOOD; BODY FAT DISTRIBUTION; BODY MASS; CHILD; CROSS-SECTIONAL STUDY; FEMALE; FORECASTING; HUMAN; MALE; METABOLIC SYNDROME X;

ADOLESCENT; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FORECASTING; HUMANS; MALE; METABOLIC SYNDROME X;

EID: 84887888086     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.5.6625     Document Type: Article

References (36)

1. Damiani D, Kuba VM, Cominato L, et al. Metabolic syndrome in children and adolescents: doubts about terminology but not about cardiometabolic risks. Arq Bras Endocrinol Metab 2011; 55/8: 576-82.
2. Instituto Brasileiro de Geografía e Estatística (2010). Pesquisa de orçamentos familiares 2008/2009. URL:http://www.ibge.gov.br/home/estatistica/populacao/condicaodevida/pof/2008_2009_encaa/pof_20082009_encaa.pdf.
3. Cook S, Weitzman M, Auinger P et al. Prevalence of a metabolic syndrome phenotypes in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch PediatrAdolesc Med 2003; 157: 821-7.
4. Ferranti SD, Grauveau K, Ludwig, D et al. Prevalence of the Metabolic Syndrome in American Adolescents: Findings From the Third National Health and Nutrition Examination Survey. Circulation 2004; 110: 2494-7.
5. Goodman E, Daniels SR, Morrison JA et al. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediat 2004; 145: 445-51.
6. Lambert M, Paradis G, O'loughlin J et al. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Inter J Obesity 2004; 28: 833-41.
7. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among US youth. Diabetes Care 2005; 28: 878-81.
8. Jollife CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. JACC 2007; 49: 891-8.
9. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Current Diabetes Reports 2004; 4: 53-62.
10. Kraja AT, Province MA, Arnett D et al. Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutrition & Metabolism 2007; 28/4: 4-28.
11. Monteiro R, Azevedo I. Chronic Inflammation in Obesity and the Metabolic Syndrome. Hindawi Publishing Corporation Mediators of Inflammation 2010; 1-10.
12. Kushner I, Rzewnicki D, Damols D. What does minor elevation of C-reactive protein signify? Am J Med 2006; 119/166: 17-28.
13. Wang C, Sun C. C-reactive Protein and Malignancy: Clinicopathological Association and Therapeutic Implication. Chang Gung Med J 2009; 32/5: 471-82.
14. Plutzky J. Inflammation in atherosclerosis and diabetes mellitus. Rev Endocr Metabolic Disorders 2004; 5: 255-9.
15. Kushner I, Rzewnicki D, Damols D. What does minor elevation of C-reactive protein signify? Am J Med 2006; 119/166: 17-28.
16. World Health Organization. Measuring obesity - classification and description of anthropometric data. Report on a WHO consultation on the epidemiology of obesity. Copenhagen: WHO Regional Office for Europe; 1987. [EUR/ICP/NUT 125,0612v].
17. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity world-wide: international survey. BML 2000; 320: 1240-5. Available at: http://bmj.bmjjournals.com/cgi/reprint/320/7244/1240
18. Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007; 85/9: 660-7.
19. Williams DP, Going BS, Lohaman TG et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health 1992; 82: 358-63.
20. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia: VI Diretrizes Brasileiras de Hipertensão Arterial. J Bras Nefr 2010; p. 1-72.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18/6: 499-502.
22. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
23. Visser M, Bouter LM, Mcquillan GM et al. Low grade systemic inflammation in overweight children. Pediatrics 2001; 107/1: 1-13.
24. Bergman R, Mittelman S. Central role of the adipocyte in insulin resistance. J Basic Clin Physiol Pharmacol 1998; 9: 205-21.
25. Lau D, Yan H, Abdel-hafez M, Kermouni A. Adipokines and the paracrine control of their production in obesity and diabetes. Int J Obes Relat Metab Disord 2002; 26: S111.
26. Fernandes AC, Gazzinelli A, Velásquez-Meléndez JG. Associação entre medidas de adiposidade, variáveis demográficas e bioquímicas com os níveis séricos de proteína C reativa em população rural. Arch Latinoamericanos Nutric 2009; 59/1: 54-60.
27. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999; 22: 1971-7.
28. Kamal NN, Ragy MM. The effects of exercise on C-reactive protein, insulin, leptin and some cardiometabolic risk factors in Egyptian children with or without metabolic syndrome. Diabetology & Metabolic Syndrome 2012; 27/4: 1-17.
29. Silva IT, Sanches LB, Mello APQ, Damasceno NRT. Impact of C-Reactive Protein on Cardiovascular Risk in Adolescents. URL: http://www.arquivosonline.com.br
30. Stewart PM. Tissue-specific Cushing's syndrome uncovers a new target in treating the Metabolic syndrome -11β-hydroxys-teroid dehydrogenase type 1. Clin Med 2005; 5: 142-6.
31. Ogawa Y. Homeostatic inflammation, an emerging concept. Endoc J 2010; 57/8: 657-8.
32. Mackelvie KJ, Meneilly GS, Elahi D et al. Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. J Clin Endocrinol Metabol 2007; 92: 648-54.
33. Maison P, Byrne CD, Hales CN, Day NE, Wareham NJ. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care 2001; 24/10: 1758-63.
34. Srinivasan SR, Myers L, Berenson GS. Predictability of child-hood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 2002; 51/1: 204-9.
35. Reaven GM: The role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
36. Freitas ED, Haddad JP, Velasquez-Melendez G. A multidimensional exploration of metabolic syndrome components. Cad Saude Publica 2009; 25/5: 1073-82.